Search
Dehydrocholic acid
go.drugbank.com/drugs/DB11622ApprovedThe use of dehydrocholic acid in over-the-counter products has been discontinued by Health Canada.
Products: Dycholium Tablet 300mgIopromide
go.drugbank.com/drugs/DB09156Approved[A260751] Approved by the FDA in 1995 and Health Canada in 1994 under the brand name ULTRAVIST, iopromide is used in radiological diagnosis, including, but not limited to, intra-arterial digital subtraction … It functions as a contrast agent by opacifying blood vessels in the flow path of the contrast agent, permitting radiographic visualization of the internal structures until significant hemodilution occurs
Products: ULTRAVIST 300MG/ML ENJEKSIYON/INFUZYON ICIN COZELTI , 500 ML, ULTRAVIST 300MG/ML ENJEKSIYON/INFUZYON ICIN COZELTI , 50 MLTubocurarine
go.drugbank.com/drugs/DB01199ApprovedWithdrawn[A216038] Tubocurarine's clinical use was limited by its relatively long duration of action (30-60 minutes)[A216038] and a number of significant side effects. … [A216028] It was first isolated by Harold King in 1935 and was used clinically to induce neuromuscular blockade during surgeries, particularly those involving the abdomen.
Products: Tubocurarine Chloride Inj 3mg/ml, Tubocurarine Chloride Inj 3mg/ml USPTriflusal
go.drugbank.com/drugs/DB08814ApprovedWithdrawnTriflusal is a 2-acetoxy-4-trifluoromethylbenzoic acid and it is an aspirin chemically-related molecule but not a derivative. … [A31675] It is very important as a secondary prevention of ischemic stroke by offering a lower risk of bleeding.[A31676] It was developed by J.
Products: GRENDIS 300MG CAPSULEFenoprofen
go.drugbank.com/drugs/DB00573ApprovedIt is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.
Products: Nalfon Cap 300mgPregabalin
go.drugbank.com/drugs/DB00230ApprovedInvestigational[L1006,L7066] It may have dependence liability if misused but the risk appears to be highest in patients with current or past substance use disorders.[A31161] … [A187190,L7066] Pregabalin is marketed by Pfizer under the trade name Lyrica and Lyrica Cr (extended release).
Mixtures: BEGOLIN PLUS 300MG/1MG FILM TABLET, 56 ADETProducts: LYRICA 300MG, LYRICA 300MG HKPPantothenic acid
go.drugbank.com/drugs/DB01783ApprovedInvestigationalNutraceuticalVet approvedPantothenic acid, also called pantothenate or vitamin B5 (a B vitamin), is a water-soluble vitamin discovered by Roger J. Williams in 1919.
Mixtures: B Complex With C 300mg, B Complex Plus C 300mg TabProducts: Vita-tenic Cap 300mg, Pantothenic Acid Tablets 300mgAmivantamab
go.drugbank.com/drugs/DB16695ApprovedInvestigational[A235133] Amivantamab was granted FDA approval on 21 May 2021,[L34193] followed by the approval by the EMA on 9 December 2021 [L41474] and Health Canada on 30 March 2022. … approved for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by
Products: RYBREVANT 350mg/7mL Concentrate for Solution for InfusionZofenopril
go.drugbank.com/drugs/DB13166ApprovedInvestigationalZofenopril is employed as both a cardioprotective and anti-hypertensive agent. It is an angiotensin-converting enzyme (ACE) inhibitor.
Mixtures: ZOFENIL PLUS 30MG/12.5MGProducts: ZOFENIL 30MG, ZOFENIL 60MGAtorvastatin
go.drugbank.com/drugs/DB01076ApprovedInvestigational[A181397, A181403] Atorvastatin was first synthesized in 1985 by Dr. Bruce Roth and approved by the FDA in 1996. … By inhibiting the endogenous production of cholesterol in the liver, statins lower abnormal cholesterol and lipid levels, and ultimately reduce the risk of cardiovascular disease.
Mixtures: ATOZET (10MG/10MG), ATOZET (10MG/80MG)Products: ATORVASTATIN AL 30MG, ATORVASTATIN PUR 30MG